Ozempic Shows Benefit in Type 1 Diabetes Patients With Obesity

GLP-1 drug helped type 1 diabetes patients keep healthy glucose levels and lose weight

Obesity drugs were first approved to treat type 2 diabetes, but there’s a growing movement to test them in type 1 diabetes, too. Research presented Monday at a large diabetes meeting showed some promise for this approach. Patients who took a GLP-1 drug fared better than those in a control group at keeping their blood glucose levels in a healthy range while also losing more weight than those who weren’t taking the drug. The double-blinded, random…

Weekly semaglutide improves blood sugar and weight in adults with type 1 diabetes, clinical trial finds

A new clinical trial found that taking a popular diabetes and weight-loss drug once weekly significantly improves blood sugar and leads to substantial weight loss in adults with type 1 diabetes who use automated insulin delivery systems.

Ozempic Shows Benefit in Type 1 Diabetes Patients With Obesity

(MedPage Today) -- CHICAGO -- Semaglutide (Ozempic) reduced glucose levels and weight among patients with type 1 diabetes and obesity, a randomized trial showed. In this 26-week, double-blind trial of 72 adults, 36% who received 1 mg of the...